NEW YORK (GenomeWeb News) - Invitrogen said yesterday that it has purchased two molecular probe product lines from TEF Labs.
The purchase gives Invitrogen TEF Labs' fluo3 and fluo4 product lines and all related intellectual property. Invitrogen's Molecular Probes business will assume the manufacture and sale of fluo 3 and fluo 4.
TEF Labs divested the product lines in order to "focus our resources on the development of new products and technologies," said Akwasi Minta, CEO of TEF Labs, in a statement.
Financial details were not disclosed.
The acquisition is Invitrogen's second announced this month. On Sept. 1, the company said that it plans to acquire cell-based assay company Sentigen Holding for around $25.9 million in cash